Cargando…
Treatment of Isoniazid-Resistant Pulmonary Tuberculosis
Tuberculosis (TB) remains a threat to public health and is the leading cause of death globally. Isoniazid (INH) is an important first-line agent for the treatment of TB considering its early bactericidal activity. Resistance to INH is now the most common type of resistance. Resistance to INH reduces...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953491/ https://www.ncbi.nlm.nih.gov/pubmed/31905429 http://dx.doi.org/10.4046/trd.2019.0065 |